BRIEF — SOBI Receives Positive CHMP Opinion For Tryngolza
Oct 16 (Reuters) — Swedish Orphan Biovitrum AB (publ): Sobi Receives Positive Chmp Opinion For Tryngolza® (Olezarsen) For The Treatment Of Severe Hypertriglyceridemia (Shtg) Source text: Further company coverage: SOBIV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;)